NL
Last week, Radboudumc researchers Suzanne de Bruijn, Susanne Roosing, and research technician Florian Winkelaar received two generous donations from the DCMD working group. This group has been committed for many years to advancing research into Dominant Cystoid Macular Dystrophy (DCMD), a hereditary retinal disorder found within a large family from the Dutch province of Brabant — and one that is virtually unique worldwide.
In late 2023, Suzanne and Susanne organized an information day for this dedicated family to share the latest research developments. The event inspired family members to take action themselves, organizing a benefit concert and a fundraising campaign through the employee association of the Province of Limburg.
Their efforts culminated in the presentation of two donation cheques totaling €9,641, handed over to the researchers by the family. A meaningful contribution to ongoing research aimed at identifying the genetic defect and gaining a deeper understanding of the disease’s progression.
to view this item in Dutch please go to: Informatie voor patiënten.
Related news items
second hDMT Eye-on-Chip meeting
26 August 2025We invite all Lifelong VISION members working with IPSC models to register for the second hDMT Eye-on-Chip meeting in Amsterdam UMC, co-organised by Ingeborg Klaassen.
go to page
Celine Koster received award for best presentation at ISCEV
7 July 2025Céline Koster - de Goede received the Eberhard Dodt Award for the Best Presentation at this year’s International Society for Clinical Electrophysiology of Vision (ISCEV) Annual Symposium!
go to page
Three fantastic days at the USH2025 meeting in Nijmegen
3 July 2025Three fantastic days at the USH2025 meeting in Nijmegen! USH2025 brought together the triangle of caregivers, scientists, and the patient community in its search for a cure for the combination of progressive hearing impairment and vision loss.
go to page
succesful 4th Dutch Antisense Therapeutics Symposium held in Groningen
3 July 2025Our Lifelong VISION PI Alex Garanto co-organized this year’s DAT Symposium, which showcased significant progress in delivery technologies and antisense therapeutics, reinforcing the growing impact of this field in addressing unmet medical needs.
go to page
Lifelong VISION gaining exposure at recent meetings
27 May 2025🌟Members of the Lifelong VISION consortium were actively involved in the recent hDMT Vessels-on-Chip Theme Group meeting in Delft and the 11th Trippenhuis meeting of the Dutch Society for Cell Biology in Amsterdam.
go to page
Lifelong VISION consortium members at ARVO2025
15 May 2025Our consortium members had a great time at the ARVO2025 annual meeting!